Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio Path Holdings Inc (NASDAQ:BPTH)

1.66
Delayed Data
As of 3:59pm ET
 0.00 / 0.00%
Today’s Change
1.00
Today|||52-Week Range
3.19
+32.80%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$158.8M

Company Description

Bio-Path Holdings, Inc. is a clinical stage biotechnology company, which focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology designed to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous infusion. Bio-Path Holdings was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Maria Tari in May 10, 2007 and is headquartered in Bellaire, TX.

Contact Information

Bio-Path Holdings, Inc.
4710 Bellaire Boulevard
Bellaire Texas 77054
P:(832) 742-1357
Investor Relations:
(832) 742-1369

Employees

Shareholders

Mutual fund holders6.40%
Individual stakeholders16.53%
Other institutional14.10%

Top Executives

Peter H. NielsenChairman, President, CEO, CFO, Treasurer & CAO
Ulrich W. MuellerChief Operating Officer & Secretary
Anthony PriceDirector-Finance & Accounting
Tara SadeghiDirector-Clinical Operations
Ana Tari AshizawaDirector of Research